Stability kinetics of influenza vaccine coated onto microneedles during drying and storage

Pharmaceutical Research

Volumn 28, Issue 1, 2011, Pages 135-144

  Kim, Yeu Chun ^a   Quan, Fu Shi ^b   Compans, Richard W ^b   Kang, Sang Moo ^b   Prausnitz, Mark R ^a  

^a Georgia Institute of Technology   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

inactivated virus vaccine; influenza virus; long term stability; microneedle; trehalose

Indexed keywords

INFLUENZA VACCINE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; HEMAGGLUTINATION; IMMUNOGENICITY; KINETICS; MICRONEEDLE; MOUSE; NEEDLE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; STORAGE; SURVIVAL RATE; VIRUS PARTICLE;

ANIMALS; ANTIBODIES, VIRAL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; DRUG STORAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; MICROINJECTIONS; NEEDLES; ORTHOMYXOVIRIDAE INFECTIONS; TECHNOLOGY, PHARMACEUTICAL; TREHALOSE;

EID: 78651225461     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0134-6     Document Type: Article

References (43)

1. P Palese 2004 Influenza: old and new threats Nat Med. 10 S82 S87 1:CAS:528:DC%2BD2cXhtVeht7fN 10.1038/nm1141 (Pubitemid 40018231)
2. AS Monto SE Ohmit 2009 Seasonal influenza vaccines: evolutions and future trends Expert Rev Vaccines. 8 383 389 10.1586/erv.09.9
3. NJ Cox K Subbarao 1999 Influenza Lancet 354 1277 1282 1:STN:280:DyaK1MvkvV2mug%3D%3D 10.1016/S0140-6736(99)01241-6 (Pubitemid 29469365)
4. PC Doherty SJ Turner RG Webby PG Thomas 2006 Influenza and the challenge for immunology Nat Immunol. 7 449 455 1:CAS:528:DC%2BD28XjsFagsLw%3D 10.1038/ni1343
5. KL Nichol JJ Treanor 2006 Vaccines for seasonal and pandemic influenza J Infect Dis. 194 S111 S118 10.1086/507544 (Pubitemid 44630954)
6. Bridges CB, Katz JM, Levandowski RA, Cox NJ. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, Offit P, editors. Vaccines. Philadelphia: Saunders Elsevier; 2008. p. 259-90.
7. Y Raviv R Blumenthal SM Tompkins J Humberd RJ Hogan M Viard 2008 Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicity J Virol. 82 4612 4619 1:CAS:528:DC%2BD1cXltVOmtbo%3D 10.1128/JVI.02233-07 (Pubitemid 351563697)
8. M Kermode 2004 Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses Health Promot Int. 19 95 103 10.1093/heapro/dah110 (Pubitemid 38364808)
9. JG Hamilton 1995 Needle phobia-a neglected diagnosis J Fam Pract. 41 169 175 1:STN:280:DyaK2MzmtleqsQ%3D%3D
10. E Drucker PG Alcabes PA Marx 2001 The injection century: massive unsterile injections and the emergence of human pathogens Lancet 358 1989 1992 1:STN:280:DC%2BD3MnpvFaqsg%3D%3D 10.1016/S0140-6736(01)06967-7 (Pubitemid 34072887)
11. Weniger BG, Papania MJ. Alternative vaccine delivery methods. In: Plotkin SA, Orenstein WA, Offit P, editors. Vaccines. Philadelphia: Saunders Elsevier; 2008. p. 1357-92.
12. S Mitragotri 2005 Immunization without needles Nat Rev Immunol. 5 905 916 1:CAS:528:DC%2BD2MXht1KntrzK 10.1038/nri1728 (Pubitemid 41746760)
13. D Holland R Booy F De Looze P Eizenberg J McDonald J Karrasch, et al. 2008 Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial J Infect Dis. 198 650 658 10.1086/590434
14. RT Kenney SA Frech LR Muenz CP Villar GM Glenn 2004 Dose sparing with intradermal injection of influenza vaccine N Engl J Med. 351 2295 2301 1:CAS:528:DC%2BD2cXhtValtr7J 10.1056/NEJMoa043540 (Pubitemid 39552745)
15. RB Belshe 2004 Current status of live attenuated influenza virus vaccine in the US Virus Res. 103 177 185 1:CAS:528:DC%2BD2cXktF2kt7c%3D 10.1016/j.virusres.2004.02.031 (Pubitemid 38649077)
16. ZY Chen C Santos A Aspelund L Gillim-Ross H Jin G Kemble, et al. 2009 Evaluation of live attenuated influenza A virus H6 vaccines in mice and ferrets J Virol. 83 65 72 1:CAS:528:DC%2BD1MXotlClsb4%3D 10.1128/JVI.01775-08
17. YC Kim FS Quan DG Yoo RW Compans SM Kang MR Prausnitz 2010 Enhanced memory responses to H1N1 influenza vaccination in the skin using vaccine coated-microneedles J Infect Dis. 201 190 198 1:CAS:528:DC%2BC3cXhvFSmsr0%3D 10.1086/649228
18. MR Prausnitz JA Mikszta M Cormier AK Andrianov 2009 Microneedle-based vaccines Curr Top Microbiol Immunol. 333 369 393 1:CAS:528:DC%2BC3cXitFCqsrs%3D 10.1007/978-3-540-92165-3-18
19. G Widera J Johnson L Kim L Libiran K Nyam PE Daddona, et al. 2006 Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system Vaccine 24 1653 1664 1:CAS:528:DC%2BD28XhsF2gsr4%3D 10.1016/j.vaccine.2005.09.049 (Pubitemid 43238242)
20. HS Gill MR Prausnitz 2007 Coated microneedles for transdermal delivery J Control Release 117 227 237 1:CAS:528:DC%2BD2sXht1Cmsbs%3D 10.1016/j.jconrel. 2006.10.017 (Pubitemid 46161873)
21. DG Koutsonanos MDP Martin VG Zarnitsyn SP Sullivan RW Compans MR Prausnitz, et al. 2009 Transdermal influenza immunization with vaccine-coated microneedle arrays PLoS ONE 4 e4773 10.1371/journal.pone.0004773
22. QY Zhu VG Zarnitsyn L Ye ZY Wen YL Gao L Pan, et al. 2009 Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge Proc Natl Acad Sci USA 106 7968 7973 1:CAS:528:DC%2BD1MXmt1amt74%3D 10.1073/pnas.0812652106
23. AK Andrianov DP DeCollibus HA Gillis HH Kha A Marin MR Prausnitz, et al. 2009 Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization Proc Natl Acad Sci USA 106 18936 18941 1:CAS:528:DC%2BD1MXhsFGqsrnJ 10.1073/pnas.0908842106
24. HS Gill DD Denson BA Burris MR Prausnitz 2008 Effect of microneedle design on pain in human volunteers Clin J Pain 24 585 594 10.1097/AJP. 0b013e31816778f9
25. YC Kim FS Quan RW Compans SM Kang MR Prausnitz 2010 Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity J Control Release 142 187 195 1:CAS:528: DC%2BC3cXhvFehuro%3D 10.1016/j.jconrel.2009.10.013
26. WLJ Hinrichs MG Prinsen HW Frijlink 2001 Inulin glasses for the stabilization of therapeutic proteins Int J Pharm. 215 163 174 1:CAS:528:DC%2BD3MXhslelur4%3D 10.1016/S0378-5173(00)00677-3 (Pubitemid 32206614)
27. WQ Sun AC Leopold LM Crowe JH Crowe 1996 Stability of dry liposomes in sugar glasses Biophys J. 70 1769 1776 1:CAS:528:DyaK28XhvVGjsrk%3D 10.1016/S0006-3495(96)79740-0
28. RM Bieganski A Fowler JR Morgan M Toner 1998 Stabilization of active recombinant retroviruses in an amorphous dry state with trehalose Biotechnol Prog. 14 615 620 1:CAS:528:DyaK1cXkvFKgtbY%3D 10.1021/bp980057d (Pubitemid 28382655)
29. JP Amorij J Meulenaar WLJ Hinrichs T Stegmann A Huckriede F Coenen, et al. 2007 Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying Vaccine 25 6447 6457 1:CAS:528:DC%2BD2sXovFOjtbg%3D 10.1016/j.vaccine.2007.06.054 (Pubitemid 47198923)
30. MD Molina TK Armstrong Y Zhang MM Patel YK Lentz TJ Anchordoquy 2004 The stability of lyophilized lipid/DNA complexes during prolonged storage J Pharm Sci 93 2259 2273 1:CAS:528:DC%2BD2cXnsVegurY%3D 10.1002/jps.20138 (Pubitemid 39129624)
31. JP Amorij A Huckriede J Wischut HW Frifflink WLJ Hinrichs 2008 Development of stable influenza vaccine powder formulations: challenges and possibilities Pharm Res. 25 1256 1273 1:CAS:528:DC%2BD1cXltFCjsbo%3D 10.1007/s11095-008-9559-6
32. YC Kim FS Quan DG Yoo RW Compans SM Kang MR Prausnitz 2009 Improved influenza vaccination in the skin using vaccine coated-microneedles Vaccine 27 6932 6938 1:CAS:528:DC%2BD1MXhtlCmsLzM 10.1016/j.vaccine.2009.08.108
33. FS Quan YC Kim DG Yoo RW Compans MR Prausnitz SM Kang 2009 Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin PLoS ONE 4 e7152 10.1371/journal.pone.0007152
34. Y Berhane M Demissie 2000 Cold chain status at immunisation centres in Ethiopia East Afr Med J. 77 476 479 1:STN:280:DC%2BD3szjt1Sjtw%3D%3D
35. BR Bloom 1989 Vaccines for the third-world Nature 342 115 120 1:STN:280:DyaK3c%2FksVSlsg%3D%3D 10.1038/342115a0 (Pubitemid 20431408)
36. M Ameri PE Daddona YF Maa 2009 Demonstrated solid-state stability of parathyroid hormone PTH(1-34) coated on a novel transdermal microprojection delivery system Pharm Res. 26 2454 2463 1:CAS:528:DC%2BD1MXhtVygsb3N 10.1007/s11095-009-9960-9
37. FS Quan RW Compans HH Nguyen SM Kang 2008 Induction of heterosubtypic immunity to influenza virus by intranasal immunization J Virol. 82 1350 1359 1:CAS:528:DC%2BD1cXhtFOktb0%3D 10.1128/JVI.01615-07
38. JC Hierholz MT Suggs 1969 Standardized viral hemagglutination and hemagglutination-inhibition test. I. Standardization of erythrocyte suspensions Appl Microbiol. 18 816 823
39. I Skountzou FS Quan J Jacob RW Compans SM Kang 2006 Transcutaneous immunization with inactivated influenza virus induces protective immune responses Vaccine 24 6110 6119 1:CAS:528:DC%2BD28XotV2ntb0%3D 10.1016/j.vaccine.2006.05.014 (Pubitemid 44175614)
40. B Spellberg JE Edwards 2001 Type 1 type 2 immunity in infectious diseases Clin Infect Dis. 32 76 102 1:STN:280:DC%2BD3M7jt1Kltg%3D%3D 10.1086/317537 (Pubitemid 32150953)
41. DA Steinhauer 1999 Role of hemagglutinin cleavage for the pathogenicity of influenza virus Virology 258 1 20 1:CAS:528:DyaK1MXivFOqt7s%3D 10.1006/viro.1999.9716 (Pubitemid 29391776)
42. F Coenen JTBM Tolboom HW Frijlink 2006 Stability of influenza sub-unit vaccine-does a couple of days outside the refrigerator matter? Vaccine 24 525 531 1:CAS:528:DC%2BD28XkvVeh 10.1016/j.vaccine.2005.07.081 (Pubitemid 41832557)
43. PH Lambert PE Laurent 2008 Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 26 3197 3208 1:CAS:528:DC%2BD1cXnt1SmtLc%3D 10.1016/j.vaccine.2008.03.095